Alternatives to Domainex

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Life science company pioneering drug discovery with AI and advanced technologies.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Mapping cell-cell communication at scale in human tissue.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company focused on developing treatments for rare metabolic diseases.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery and development platform for biologics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Advance every cancer decision.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.